BAMS
MGNX icon

Bellevue Asset Management (Switzerland)’s MacroGenics MGNX Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$2.57M Hold
83,000
– – 0.39% 73
2015
Q3 		$1.78M Buy
83,000
+2,000
+2% +$62.7K 0.29% 88
2015
Q2 		$3.08M Buy
81,000
+66,000
+440% +$2.17M 0.43% 73
2015
Q1 		$471K Buy
+15,000
New +$508K 0.07% 134

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s MGNX Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its MacroGenics (MGNX) position steady in Q4 2015 at 83,000 shares worth $2.57M. The position accounts for 0.39% of the portfolio, ranked #73.

Bellevue Asset Management (Switzerland) first reported a position in MGNX in Q1 2015 and has held it in 4 quarters since. The position peaked at $3.08M in Q2 2015. 128 funds tracked by Wall St. Rank hold MGNX as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 83,000 shares of MacroGenics worth $2.57M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) left its MacroGenics share count unchanged in Q4 2015.
  • MacroGenics made up 0.39% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #73 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in MacroGenics in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s MacroGenics position peaked at $3.08M in Q2 2015.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.